severe dystonia, doesn't allow me to use my feet or hands.; Immediately sick; headache; I have had a migraine since and it will not go away.; POTS; Fibromyalgia; BVD; my health worsened; My vision has decreased and is blurry; My vision has decreased and is blurry; My vision over lapping, or double.; I am constantly dizzy and cannot tolerate being upright.; My body is in constant pain; muscle spasms; issues with my heart rate; Blood pressure increases; Blood pressure decreases; Fall risk, prone to fainting; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 28-year-old female patient received bnt162b2 (BNT162B2), on 18Mar2021 at 10:30 as dose 1, single (Lot number: EN6208) at the age of 28 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "iih" (unspecified if ongoing); "depression" (unspecified if ongoing). Concomitant medication(s) included: PROZAC; POTASSIUM; DIAMOX [ACETAZOLAMIDE]; VIT D [VITAMIN D NOS]; MAGNESIUM; RIBOFLAVIN. Past drug history included: Amoxicillin, reaction(s): "known allergies". The following information was reported: VISUAL IMPAIRMENT (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "BVD"; BLOOD PRESSURE DECREASED (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "Blood pressure decreases"; BLOOD PRESSURE INCREASED (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "Blood pressure increases"; PRESYNCOPE (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "Fall risk, prone to fainting"; FIBROMYALGIA (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered"; DIZZINESS POSTURAL (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "I am constantly dizzy and cannot tolerate being upright."; MIGRAINE (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "I have had a migraine since and it will not go away."; ILLNESS (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "Immediately sick"; PAIN (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "My body is in constant pain"; VISUAL IMPAIRMENT (hospitalization, disability), VISION BLURRED (hospitalization, disability) all with onset 18Mar2021 at 10:30, outcome "not recovered" and all described as "My vision has decreased and is blurry"; DIPLOPIA (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "My vision over lapping, or double."; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "POTS"; HEADACHE (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered"; HEART RATE ABNORMAL (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "issues with my heart rate"; MUSCLE SPASMS (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered"; CONDITION AGGRAVATED (hospitalization, disability) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "my health worsened"; DYSTONIA (hospitalization, disability, medically significant) with onset 18Mar2021 at 10:30, outcome "not recovered", described as "severe dystonia, doesn't allow me to use my feet or hands.". The patient was hospitalized for dystonia, illness, headache, migraine, postural orthostatic tachycardia syndrome, fibromyalgia, visual impairment, condition aggravated, visual impairment, vision blurred, diplopia, dizziness postural, pain, muscle spasms, heart rate abnormal, blood pressure increased, blood pressure decreased, presyncope (hospitalization duration: 4 day(s)). The events "severe dystonia, doesn't allow me to use my feet or hands.", "immediately sick", "headache", "i have had a migraine since and it will not go away.", "pots", "fibromyalgia", "bvd", "my health worsened", "my vision has decreased and is blurry", "my vision over lapping, or double.", "i am constantly dizzy and cannot tolerate being upright.", "my body is in constant pain", "muscle spasms", "issues with my heart rate", "blood pressure increases", "blood pressure decreases" and "fall risk, prone to fainting" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: (unspecified date) decreases, notes: Blood pressure increases and decreases to dangerous levels; (unspecified date) increases, notes: Blood pressure increases and decreases to dangerous levels; Heart rate: (unspecified date) issues with my heart rate; SARS-CoV-2 test: (01Oct2021) Inconclusive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of dystonia, illness, headache, migraine, postural orthostatic tachycardia syndrome, fibromyalgia, visual impairment, condition aggravated, visual impairment, vision blurred, diplopia, dizziness postural, pain, muscle spasms, heart rate abnormal, blood pressure increased, blood pressure decreased, presyncope. Clinical course: immediately sick and had headache. Patient have had a migraine since and it will not go away. Caused POTS, Fibromyalgia, BVD, and other Illnesses. After the vaccine, patient went to the ER 4 times before being admitted into the hospital for an intractable migraine and was released still in pain and sick. For over 2 years after the vaccine patient continued to collect symptoms and her health worsened. Her vision had decreased and was blurry, over lapping, or double. Patient was constantly dizzy and cannot tolerate being upright. Her body was in constant pain and the severe dystonia did not allow her to use her feet or hands. Constant muscle spasms and issues with heart rate. Blood pressure increases and decreases to dangerous levels. Fall risk, prone to fainting. Patient had dose 2 (lot number: ER8729) on 09Apr2021 at 04:30 PM on right arm.